Pfizer close to out-of-court deal with Nigeria
This article was originally published in Scrip
Executive Summary
Pfizer is close to agreeing a multi-million dollar out-of-court settlement for legal cases in Nigeria over its 1996 clinical trial for its antibiotic Trovan (trovafloxacin).